Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
Mats Borén, Ph.D., works as head of development at Denator.
More GEN Content From This Contributor:
- Tutorials: Stabilization Method for Biological Samples
- Tutorials: Improving Molecular Distribution Analysis
- Columns: The 11 Golden Rules of Working with Proteomic Samples
- Tutorials: Improved Metabolomic Studies